Trials / Completed
CompletedNCT01076257
Efficacy of Modified Constraint-induced Movement Therapy in Children With Brain Damage
Efficacy of Modified Constraint-induced Movement Therapy in Children With Brain Damage: Evidence of Kinematic Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- Chang Gung Memorial Hospital · Academic / Other
- Sex
- All
- Age
- 4 Years – 15 Years
- Healthy volunteers
- Not accepted
Summary
This research centers on the comparison of the immediate efficacy (right after therapy) and the maintained efficacy (3 months and 6 months) between "Modified Constraint-Induced Movement Therapy" (mCIMT) group and control group at different age.
Detailed description
"Modified Constraint-Induced Movement Therapy" is one of the most recent treatments for children with Brain damage. This well-designed and follow-up RCT study compared home-based CIT with a control intervention (traditional rehabilitation, TR) by combining kinematic analysis and clinical evaluation, which is possible to examine whether functional improvement is accompanied by a change in motor control. We hypothesized that home-based CIT would induce better motor control strategies (shorter RT, MT, lesser MUs, MGA, and PMGA, and larger peak velocity (PV)) for greater functional gains than TR. Furthermore, the beneficial effects would be maintained at 3 and 6 months of follow-up. Findings of this study allow clinicians to understand the underlying motor control changes for functional improvement after home-based CIT.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Modified Constraint-induced Movement Therapy | Home based CIT 1. Restriction of the less affected limb 2. Intensive practice using affected limb 3. Positive experience 4. Functional task (task) |
Timeline
- Start date
- 2009-06-01
- Primary completion
- 2010-07-01
- Completion
- 2010-07-01
- First posted
- 2010-02-26
- Last updated
- 2012-07-31
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT01076257. Inclusion in this directory is not an endorsement.